Nutriband seeks dual listing as it nears market launch for fentanyl patch

Nasdaq-listed pharma company seeks Upstream listing ahead of FDA approval for its Aversa-based abuse deterrent patches

Gareth Sheridan, founder and chief executive, Nutriband: ‘As of today, our market cap is maybe a third of what I expect our gross profit to be in a year or two.’ Picture: Vanja Savic

Nutriband, an Irish-founded pharma company, is seeking a dual listing for its shares on the Upstream digital stock exchange. The company, which is already listed on the Nasdaq and valued at around €30 million, is developing a fentanyl patch that incorporates abuse deterrent technology.

Upstream is a fully regulated global stock exchange for digital securities such as non-fungible tokens (NFTs) that has been developed using Ethereum blockchain technology. Its backers include the rapper Pitbull as ...